Hormonal
Regular physical activity (aerobic and resistance) is a major therapeutic modality for type 2 diabetes, improving glucose tolerance and insulin sensitivity, but these benefits deteriorate within 72 hours of the last session, necessitating frequent exercise.
To manage type 2 diabetes, you need to exercise regularly because the benefits wear off after about 3 days. Aim for at least 1000 calories of exercise per week, spread over 3-5 days. Start with low-to-moderate intensity (like brisk walking) for 10-15 minutes, gradually building up to 30 minutes. If you have foot problems, try non-weight-bearing exercises like swimming or cycling. Use how you feel (RPE) to gauge intensity if your heart rate response is affected by neuropathy. Consistency is key to keeping your blood sugar and insulin sensitivity improved.
Physical activity, including appropriate endurance and resistance training, is a major therapeutic modality for type 2 diabetes... Favorable changes in glucose tolerance and insulin sensitivity usually deteriorate within 72 h of the last exercise session; consequently, regular physical activity is imperative to sustain glucose-lowering effects and improved insulin sensitivity.
Why this rating
This is a Position Stand from the American College of Sports Medicine, representing a consensus of expert opinion and extensive literature review.
Source
Exercise and Type 2 Diabetes
A. Albright et al. · Medicine & Science in Sports & Exercise · 2000
DOI 10.1097/00005768-200007000-00024
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →